- Home
- UPXI vs TKNO Comparison
UPXI vs TKNO Comparison
Compare UPXI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- TKNO
- Stock Information
- Founded
- UPXI 2018
- TKNO 1996
- Country
- UPXI United States
- TKNO United States
- Employees
- UPXI N/A
- TKNO N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- UPXI Health Care
- TKNO Health Care
- Exchange
- UPXI Nasdaq
- TKNO Nasdaq
- Market Cap
- UPXI 481.8M
- TKNO 256.9M
- IPO Year
- UPXI 2021
- TKNO 2021
- Fundamental
- Price
- UPXI $7.23
- TKNO $4.35
- Analyst Decision
- UPXI
- TKNO
- Analyst Count
- UPXI 0
- TKNO 0
- Target Price
- UPXI N/A
- TKNO N/A
- AVG Volume (30 Days)
- UPXI 8.1M
- TKNO 224.0K
- Earning Date
- UPXI 05-16-2025
- TKNO 08-07-2025
- Dividend Yield
- UPXI N/A
- TKNO N/A
- EPS Growth
- UPXI N/A
- TKNO N/A
- EPS
- UPXI N/A
- TKNO N/A
- Revenue
- UPXI $16,562,327.00
- TKNO $38,923,000.00
- Revenue This Year
- UPXI $299.03
- TKNO $9.52
- Revenue Next Year
- UPXI N/A
- TKNO $15.20
- P/E Ratio
- UPXI N/A
- TKNO N/A
- Revenue Growth
- UPXI 1378.83
- TKNO 11.40
- 52 Week Low
- UPXI $1.90
- TKNO $4.00
- 52 Week High
- UPXI $22.57
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- UPXI 51.85
- TKNO 43.35
- Support Level
- UPXI $6.16
- TKNO $4.22
- Resistance Level
- UPXI $9.12
- TKNO $4.94
- Average True Range (ATR)
- UPXI 0.97
- TKNO 0.29
- MACD
- UPXI 0.10
- TKNO -0.00
- Stochastic Oscillator
- UPXI 47.86
- TKNO 16.75
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via a Solana treasury strategy.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.